You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu


Janssen reveals new Spravato data

The Janssen Pharmaceutical Companies of Johnson & Johnson has announced new findings from its pivotal ESCAPE-TRD trial.